A Phase Ii Study Of Regorafenib In Patients With Thymic Epithelial Tumours Previously Treated With Chemotherapy.
JOURNAL OF CLINICAL ONCOLOGY(2018)
Abstract
8579Background: Angiogenesis has an important role in thymic epithelial tumours (TETs); VEGF, PDGF and PDGFRα are overexpressed in TETs, and VEGF expression and microvessel density are associated w...
MoreTranslated text
Key words
thymic epithelial tumours,regorafenib,chemotherapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined